210 related articles for article (PubMed ID: 7848345)
1. Preclinical testing of iopromide. 2nd communication: toxicological evaluation.
Krause W; Schöbel C; Press WR
Arzneimittelforschung; 1994 Nov; 44(11):1275-9. PubMed ID: 7848345
[TBL] [Abstract][Full Text] [Related]
2. Preclinical testing of iopromide. 1st communication: pharmacological evaluation.
Krause W; Press WR; Frenzel T
Arzneimittelforschung; 1994 Oct; 44(10):1162-6. PubMed ID: 7529504
[TBL] [Abstract][Full Text] [Related]
3. Preclinical safety evaluation of Gd-EOB-DTPA (Primovist).
Döhr O; Hofmeister R; Treher M; Schweinfurth H
Invest Radiol; 2007 Dec; 42(12):830-41. PubMed ID: 18007155
[TBL] [Abstract][Full Text] [Related]
4. Preclinical characterization of iopromide-carrying liposomes.
Krause W; Sachse A; Wagner S; Kollenkirchen U; Rössling G
Invest Radiol; 1991 Nov; 26 Suppl 1():S172-4; discussion S175-6. PubMed ID: 1808120
[No Abstract] [Full Text] [Related]
5. Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging.
Leike JU; Sachse A; Rupp K
Invest Radiol; 2001 Jun; 36(6):303-8. PubMed ID: 11410749
[TBL] [Abstract][Full Text] [Related]
6. [Preclinical toxicological study of D-glucuronic acid].
Karpova GV; Fomina TI; Vetoshkina TV; Borovskaia TG; Voronova OL; Dubskaia TIu; Udut VV; Khlusova MIu
Eksp Klin Farmakol; 2001; 64(1):68-70. PubMed ID: 11544811
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
[TBL] [Abstract][Full Text] [Related]
8. Toxicological safety evaluation of gadobutrol.
Wack C; Steger-Hartmann T; Mylecraine L; Hofmeister R
Invest Radiol; 2012 Nov; 47(11):611-23. PubMed ID: 23011188
[TBL] [Abstract][Full Text] [Related]
9. Toxicologic profile of iobitridol, a new nonionic low-osmolality contrast medium.
Donandieu AM; Idee JM; Doucet D; Legros A; Penati S; Nain-Dit-Ducret M; Marmion F; Bonnemain B
Acta Radiol Suppl; 1996; 400():17-24. PubMed ID: 8619348
[TBL] [Abstract][Full Text] [Related]
10. Neurotolerability of nonionic X-ray contrast media. The role of chemotoxicity.
Luzzani F; Morisetti A; Bussi S; Tirone P; de Haën C
Invest Radiol; 1996 Jun; 31(6):338-44. PubMed ID: 8761866
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity of non-ionic X-ray contrast media after intracisternal administration in rats.
Wible JH; Barco SJ; Scherrer DE; Wojdyla JK; Adams MD
Eur J Radiol; 1995 Mar; 19(3):206-11. PubMed ID: 7601172
[TBL] [Abstract][Full Text] [Related]
12. Toxicological investigations with nimodipine. Summary of relevant studies.
Schlüter G
Arzneimittelforschung; 1986 Dec; 36(12):1733-5. PubMed ID: 3566834
[TBL] [Abstract][Full Text] [Related]
13. Toxicological profile of a low molecular weight spleen peptide formulation used in supportive cancer therapy.
Hartleb M; Leuschner J
Arzneimittelforschung; 1997 Sep; 47(9):1047-51. PubMed ID: 9342421
[TBL] [Abstract][Full Text] [Related]
14. Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats.
Doerfler A; Engelhorn T; von Kummer R; Weber J; Knauth M; Heiland S; Sartor K; Forsting M
Radiology; 1998 Jan; 206(1):211-7. PubMed ID: 9423675
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron: pre-clinical safety evaluation.
Tucker ML; Jackson MR; Scales MD; Spurling NW; Tweats DJ; Capel-Edwards K
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S79-93. PubMed ID: 2533905
[TBL] [Abstract][Full Text] [Related]
16. Toxicity studies with flutrimazole.
Vericat ML; García Rafanell J; Forn J; Casadesús A; Alumá J; Zapatero J
Arzneimittelforschung; 1992 Jun; 42(6):841-6. PubMed ID: 1418043
[TBL] [Abstract][Full Text] [Related]
17. Toxicological properties of metaflumizone.
Hempel K; Hess FG; Bögi C; Fabian E; Hellwig J; Fegert I
Vet Parasitol; 2007 Dec; 150(3):190-5. PubMed ID: 17933467
[TBL] [Abstract][Full Text] [Related]
18. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
Morisetti A; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
[TBL] [Abstract][Full Text] [Related]
19. [The tolerability of pale sulfonated shale oil following local and systemic administration].
Cholcha W; Leuschner J; Leuschner F
Arzneimittelforschung; 1994 Feb; 44(2):170-7. PubMed ID: 7908523
[TBL] [Abstract][Full Text] [Related]
20. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
Pettersson G; Towart R; Grant D; Thyberg K; Golman K
Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
